Forte Biosciences, Inc. (FBRX)
33.92
+2.49
(+7.92%)
USD |
NASDAQ |
Apr 17, 16:00
33.70
-0.22
(-0.65%)
After-Hours: 20:00
Forte Biosciences Total Assets (Quarterly) : 82.78M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| STAAR Surgical Co. | 461.62M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Agenus, Inc. | 226.80M |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 253.44M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.79M |
| Shareholders Equity (Quarterly) | 60.99M |
| Current Ratio | 3.884 |